Re-solicitation of Cryogenic Scanning Electron-Raman Microscope System

AMENDMENT 01: The purpose of this amendment to the subject SAM.gov posting is to upload the questions and their respective responses that were received in response to the solicitation. No SF30 is issued with this action. All other terms and conditions remain unchanged. **************************************************************************************** This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Federal Acquisition Regulation (FAR) 12.6 and (FAR) 13 as supplemented with additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED. The solicitation number for this acquisition is 75F40124Q00265-01 for FDA Project CDER-2024-121914. This combined solicitation is being re-issued as a Request for Quotation (RFQ). The NAICS for this solicitation is 334516 – Analytical Laboratory Instrument Manufacturing. The small business size standard is 1,000 employees. This requirement is being solicited as Unrestricted - full and open . Prospective quoters are responsible for downloading the solicitation and any amendments from SAM.gov. The Government reserves the right to award the resultant firm fixed price purchase order without discussions if the Contracting Officer determines that the initial offer provides the Best Value to the Government and discussions are not necessary. The U. S. Food and Drug Administration (FDA) has a need to procure a one (1) Cryogenic Scanning Electron-Raman Microscope System which consist of a field emission scanning electron microscope with a cryotransfer system and includes a cryo-stage, sample loading system, sample preparation system, an ion-beam-milling system, SEM-Raman interface, and ability to retrofit an existing EDS system on behalf of the Center for Drug Evaluation and Research, Office of Pharmaceutical Quality (CDER/OPQ/OTR). Question Deadline: Questions related to this procurement shall be submitted directly by email to Contracting Officer, Sheneil Green, [email protected]. No phone calls will be accepted . Questions not received by the deadline of Monday, Aug 5, at 12:00 p.m. Eastern Time (ET) will not be considered. Quotation Deadline: The deadline for receipt of quotations is Friday, August 9, 2024, at 12:00 ET. Quotation submissions shall be submitted electronically to the Contracting Officer. Please refer to the attached solicitation. Please review its instructions and specifications in their entirety prior to submission.